Romulus Brazzell
Net worth: 436 $ as of 29/06/2026
Net worth: 436 $ as of 29/06/2026
Romulus Kim Brazzell is currently Director at Mimetogen Pharmaceuticals, Inc. since 2024 and Chief Medical Officer, Head-Research & Development at Kala Bio, Inc. since 2021.
Former positions include Associate Director-Research & Development at Alcon Laboratories, Inc. from 1990 to 1991; Executive VP-Medical & Scientific Affairs at Inspire Pharmaceuticals, Inc. from 2010 to 2011; Senior Vice President-US Research & Development at Novartis Ophthalmics, Inc. from 2000 to 2004; Chief Medical Officer at Mimetogen Pharmaceuticals, Inc. from 2012 to 2015; Vice President-Research & Development at Ciba Vision Ophthalmics Co. from 1996 to 2000; and Principal at Acuity Advisors LLC from 2014 to 2018.
Education includes undergraduate and doctorate degrees from the University of Kentucky.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 28/12/2025 | 252 ( 0% ) | 436 $ | 29/06/2026 |
| Companies | Position | Start |
|---|---|---|
| KALA BIO, INC. | Chief Tech/Sci/R&D Officer | 31/01/2013 |
Mimetogen Pharmaceuticals, Inc.
Mimetogen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops peptidomimetic small molecule drugs against glaucoma and cancer | Director/Board Member | 31/12/2023 |
| Companies | Position | End |
|---|---|---|
Acuity Advisors LLC
Acuity Advisors LLC Investment ManagersFinance Provides investment advice | Corporate Officer/Principal | 30/06/2018 |
Mimetogen Pharmaceuticals, Inc.
Mimetogen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops peptidomimetic small molecule drugs against glaucoma and cancer | Chief Tech/Sci/R&D Officer | 30/11/2015 |
Inspire Pharmaceuticals, Inc.
Inspire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes ophthalmic products | Chief Tech/Sci/R&D Officer | 31/12/2010 |
Novartis Ophthalmics, Inc.
Novartis Ophthalmics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals, eye care and generic drugs | Chief Tech/Sci/R&D Officer | 31/12/2003 |
Ciba Vision Ophthalmics Co. | Chief Tech/Sci/R&D Officer | 31/12/1999 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 8 |
|---|---|
Inspire Pharmaceuticals, Inc.
Inspire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes ophthalmic products | Health Technology |
Kala Bio, Inc.
Kala Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company developing mesenchymal stem cell secretive (MSC-S) therapies | Health Technology |
Alcon Laboratories, Inc.
Alcon Laboratories, Inc. Medical SpecialtiesHealth Technology Operates as an eye care device company | Health Technology |
University of Kentucky
University of Kentucky Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novartis Ophthalmics, Inc.
Novartis Ophthalmics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals, eye care and generic drugs | Health Technology |
Mimetogen Pharmaceuticals, Inc.
Mimetogen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops peptidomimetic small molecule drugs against glaucoma and cancer | Health Technology |
Ciba Vision Ophthalmics Co. | |
Acuity Advisors LLC
Acuity Advisors LLC Investment ManagersFinance Provides investment advice | Finance |
Select your edition
All financial news and data tailored to specific country editions